Benefits of some cancer drugs exaggerated because trials were stopped early
Italian scientists say the benefits of some cancer drugs may be exaggerated as a rising number of trials are stopped early.
Cancer treatment is entering a ``very exciting'' era as a number of projects reach fruition that could stop the disease being a major cause of death, Britain's leading cancer scientist is to claim.